Management Team

Our Management Team provides a wealth of knowledge and experience:

Liz Littlewood

Liz Littlewood

Operations Director


Liz joined the team at 272BIO Limited as Operations Director in 2019. Liz has 26 years leadership experience in the Pharma/Biotech Industry. In 1996 Liz joined the Pfizer Animal Health Group in Sandwich as a team leader in in vitro pharmacology, working across…

READ MORE

Charles Owen

Charles Owen

Founder


272BIO was founded by Charlie Owen in 2019 with the aim of delivering innovative therapeutic solutions using biotherapeutics to tackle unmet medical need across animal health. Charlie completed a PhD at Glasgow University investigating transcriptional…

READ MORE

Karine Clauwaert

Karine Clauwaert

Business Development


Karine Clauwaert joined the 272bio team in 2021 to drive business development. Karine qualified as a Pharmacist in 1992 and went on to gain a PhD in pharmaceutical sciences at Ghent University in the laboratory of toxicology in 1998. Between 1997 and 2003…

READ MORE

An Cerdobbel

An Cerdobbel

CMC Subject Matter Expert


An Cerdobbel joined 272Bio in 2021 as a CMC Subject Matter Expert. An received a PhD in Bioscience Engineering from Ghent University (2010) for work performed in the field of applied biocatalysis. She then moved to Ablynx, where she was quickly promoted from Associate Scientist…

READ MORE

Dr Christine Labeur, PhD

Dr Christine Labeur, PhD

VHH CMC Subject Matter Expert


Dr Christine Labeur, PhD Joined 272BIO in 2019 as our VHH CMC Subject Matter Expert. Since the start of her scientific career about 35 years ago Christine has been  fascinated by the complexity and biochemistry of protein research which has resulted in achieving a broad global  expertise of pharmaceutical…

READ MORE

Emma Campbell

Emma Campbell

Head of Translational Science


Emma is Translational Sciences Lead, bridging the gap between scientific and clinical fields. Emma also provides oversight of the Companion Animal Portfolio.  Emma has over 20 years’ experience in drug discovery and pre-clinical development, successfully transitioning…

READ MORE

Inês Pimenta de Castro

Inês Pimenta de Castro

Head of Portfolio Management


Inês Pimenta de Castro, PharmD, Ph.D., joned 272BIO as our Head of Portfolio Management in March 2022. Ines’ responsibilities include strategic scientific leadership, management of antibody discovery projects, external collaborations, partnerships management and operational activities. Before joining 272BIO…

READ MORE

Francois Bertelli

Francois Bertelli

Head of Antibody Discovery


Francois Bertelli is Head of Antibody Research at 272Bio, leading the discovery of new antibody/VHH formats by bringing new target ideas, formats design, and targeted delivery modalities. Francois has over 24 years of experience in the Pharma industry, having worked at Pfizer, Abbott, Spirogen, MedImmune, Astrazeneca…

READ MORE

Tom Hayward

Tom Hayward

Chief Financial Officer


Tom qualified as a chartered accountant with KPMG, and then worked in the telecoms, media and technology team at J. Henry Schroder & Co.
He spent nine years as an early stage investor with Herald Investment Management, investing and managing a portfolio of holdings in the…

READ MORE

 

Our Management Team leverages their deep industry experience, data-driven insights and strategic innovation to empower our team of advocates who deliver novel healthcare solutions that help customers succeed in an increasingly challenging business climate.

Pig&Chicken_graphicNEW